Detalles de la búsqueda
1.
Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma.
Cancer Immunol Immunother
; 73(8): 144, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38832979
2.
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells.
Cancer Cell Int
; 24(1): 181, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790057
3.
Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression.
Cancer Sci
; 113(10): 3330-3346, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35792657
4.
High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer Cell Int
; 22(1): 90, 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189899
5.
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models.
BMC Cancer
; 22(1): 752, 2022 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820889
6.
Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma.
Oncologist
; 26(7): e1161-e1170, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844372
7.
Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
Dig Dis Sci
; 66(2): 474-482, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193860
8.
A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway.
BMC Cancer
; 20(1): 1, 2019 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892356
9.
Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy.
Support Care Cancer
; 23(7): 1933-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25492636
10.
Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation.
Tumour Biol
; 35(5): 4369-75, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24515655
11.
Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
BMC Cancer
; 14: 823, 2014 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25380654
12.
The impact of transparent packaging: how transparent packaging for organic foods affects tourists' green purchasing behavior.
Front Nutr
; 11: 1328596, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406189
13.
The relationship between brain metastasis and HER2 expression status in gastric cancer.
Clin Transl Oncol
; 26(3): 765-773, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620706
14.
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors.
Clin Cancer Res
; 30(3): 506-521, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971712
15.
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.
Cell Mol Immunol
; 21(1): 60-79, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062129
16.
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
Blood
; 118(15): 4140-9, 2011 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21844567
17.
A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1.
Genes (Basel)
; 14(4)2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37107648
18.
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.
Clin Cancer Res
; 29(1): 183-196, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240005
19.
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial.
Clin Cancer Res
; 29(13): 2385-2393, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37074726
20.
Burden of tyrosine kinase inhibitor failure in Chinese chronic myeloid leukemia patients: a systematic literature review.
J Comp Eff Res
; 11(8): 621-637, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411807